Tag: Hematology
European Hematology Association: Answering the Unmet Need in One of the Most Common Types of Lymphoma: It's as Simple as A-D-C

European Hematology Association: Answering the Unmet Need in One of the Most Common Types of Lymphoma: It's as Simple as A-D-C

STOCKHOLM, June 16, 2018 /PRNewswire/ -- Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Unfortunately, 40% of patients will relapse ...

Lees verder
European Hematology Association: A New Anti-CD22 CAR-T Immunotherapy Saved Life of Children With Leukemia

European Hematology Association: A New Anti-CD22 CAR-T Immunotherapy Saved Life of Children With Leukemia

STOCKHOLM, June 16, 2018 /PRNewswire/ -- B acute lymphoblastic leukemia (B-ALL) is a fatal blood cell tumor that is usually treated with chemotherapy or allogeneic ...

Lees verder
European Hematology Association: iNNOVATE Study: Ibrutinib Plus Rituximab for Patients With Waldenström's Macroglobulinemia

European Hematology Association: iNNOVATE Study: Ibrutinib Plus Rituximab for Patients With Waldenström's Macroglobulinemia

STOCKHOLM, June 16, 2018 /PRNewswire/ -- Waldenström's Macroglobulinemia (WM) is a rare type of blood cancer. Since WM is rare, it is difficult to conduct large clinical ...

Lees verder
European Hematology Association: Iron: a double-edged Sword in Inflammation

European Hematology Association: Iron: a double-edged Sword in Inflammation

STOCKHOLM, June 15, 2018 /PRNewswire/ -- Iron is a vital element required for several biologic functions, first of all oxygen delivery to tissues, which occurs through the ...

Lees verder
European Hematology Association: Global Trial of the Efficacy and Safety of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-

European Hematology Association: Global Trial of the Efficacy and Safety of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-

MADRID, June 24, 2017 /PRNewswire/ -- CTL019 consists of genetically engineered autologous T cells expressing a chimeric antigen receptor (CAR). Results from a prior ...

Lees verder
European Hematology Association: Early Metabolic Response Determination by FDG-PET Allows Substantial Reduction of Chemotherapy and its Toxicity

European Hematology Association: Early Metabolic Response Determination by FDG-PET Allows Substantial Reduction of Chemotherapy and its Toxicity

MADRID, June 24, 2017 /PRNewswire/ -- Hodgkin lymphoma is the most common malignancy of young adults. Intensive chemotherapy with eight or six cycles of eBEACOPP is very ...

Lees verder
European Hematology Association: Clinical and Biologic Covariates of Outcomes in ZUMA-1: A Pivotal Trial of Axicabtagene Ciloleucel (axi-cel; KTE

European Hematology Association: Clinical and Biologic Covariates of Outcomes in ZUMA-1: A Pivotal Trial of Axicabtagene Ciloleucel (axi-cel; KTE

MADRID, June 24, 2017 /PRNewswire/ -- Outcomes for patients with refractory, aggressive non-Hodgkin lymphoma (NHL) are poor with current therapies. Axicabtagene ciloleucel ...

Lees verder
European Hematology Association: Multicenter Open-label Phase 2 Study of ibrutinib in Chronic Graft Versus Host Disease (cGVHD) After Failure of

European Hematology Association: Multicenter Open-label Phase 2 Study of ibrutinib in Chronic Graft Versus Host Disease (cGVHD) After Failure of

MADRID, June 24, 2017 /PRNewswire/ -- Ibrutinib: A promising new treatment for chronic graft versus host disease.  Chronic graft versus host disease (cGVHD) is a serious and ...

Lees verder
European Hematology Association: Bleeding or Clotting in Elderly Patients with Cancer-Associated Venous Thromboembolism: Which is Worse?

European Hematology Association: Bleeding or Clotting in Elderly Patients with Cancer-Associated Venous Thromboembolism: Which is Worse?

MADRID, June 24, 2017 /PRNewswire/ -- The risk of blood clots in the veins of the legs or the lungs, known as venous thrombosis (VTE) is higher in cancer patients, and so is ...

Lees verder
BizPress.nl